Ingredient research
A study may test a specific extract or nutrient. Its findings do not automatically apply to every product containing that ingredient.
THE SCIENCE EDIT
Curiosity looks good on you.
Ingredient → Preparation → Dose → Evidence
CURIOSITY. CLARITY. CARE.
Good science asks
better questions.
You deserve more than a scientific-sounding headline. You deserve to know what was studied, what was found, and what is still uncertain.
Our approach to this website is simple: make the evidence easy to explore, keep product information separate from research findings, and leave room for an informed conversation with your healthcare professional.
Three things we keep separate.
Formulation rationale
Why ingredients were selected is a different question from whether a complete formula has been shown to produce an outcome. Biological plausibility is a starting point, not proof.
Finished-product evidence
A clinical claim about Vita-Fem itself needs research on the actual formula, dose, population, and outcome. No finished-product trial is cited in this preview, so we do not present one as established.
“Clinician-formulated” describes who helped develop a formula. It does not mean “clinically proven.” Quality testing and efficacy testing also answer different questions.
A more useful way to read a study.
Look beyond a percentage in a headline. Was there a comparison group? How many people participated? Was the result meaningful in everyday life? Does the dose match the product label? Were harms and limitations reported?
Consider the full body of research, not only a single positive result. Testimonials can describe a person’s experience, but they cannot establish that a supplement caused the change or that another person will have the same result.
DR. SARAH DOYLE’S PUBLISHED WORK
Research Sarah coauthored.
These three published case reports are distinct from studies of the finished Vita-Fem products. The third concerns disordered eating and is included as related clinical work.
Doyle S, Rosen J, Knight K, Coetzee O. Integrative management of estrogen dominance, methylation impairment, and histamine intolerance in perimenopause: a case report. Archives of Healthcare. (2026) 6(1): 7-23.
Open publication ↗Doyle S, Cho PKB, Arnold D, Coetzee O. Urinary Metabolite Testing, Nutraceutical Intervention, and (the 7X Method Program) in the Management of Menopause Symptoms: A Case Report. Women's Health Research (2025), 5, 24–38.
Open publication ↗Doyle SE. Case Report: Utilization of Urinary Neurotransmitter Metabolite Testing and Natural Supplements in the Management of Disordered Eating. Nutritional Perspectives: Journal of the Council on Nutrition. (2022) 45(4):12–20.
Open publication ↗Start with reliable references.
The following government health resources provide context on ingredients and the menopause transition. Their inclusion does not imply endorsement of Vita-Fem.
- Office on Women’s Health · Menopause basics ↗
- NIH · Chaste tree berry: evidence and safety ↗
- NIH · Ashwagandha: evidence and safety ↗
- NIH · Black cohosh: evidence and safety ↗
- NIH · Magnesium: evidence and safety ↗
- NIH · Vitamin B12: evidence and safety ↗
Safety belongs in the conversation.
Bring the entire supplement label and a list of your medicines to your clinician or pharmacist. Ingredients can overlap across products. Pregnancy, breastfeeding, hormone-sensitive conditions, kidney or liver health, and upcoming surgery can change what is appropriate for you.
Supplements are not a replacement for evaluation of new or persistent symptoms. Do not stop prescribed care based on this website.
Explore the ingredient guide ↗